Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Flynn

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 24, 2015
Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) CohortBradley A Warady, Alison G Abraham, George J Schwartz, et al.
American Journal of Hematology|August 21, 2013
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphomaJeffrey A Jones, Amy S Rupert, Ming Poi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemiaJames S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Circulation|August 30, 2014
Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart AssociationDavid M Maahs, Stephen R Daniels, Sarah D de Ferranti, et al.
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Scientific Reports|September 15, 2021
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville KentuckyKrystal T Hamorsky, Adrienne M Bushau-Sprinkle, Kathleen Kitterman, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 24, 2015
Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) CohortBradley A Warady, Alison G Abraham, George J Schwartz, et al.
American Journal of Hematology|August 21, 2013
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphomaJeffrey A Jones, Amy S Rupert, Ming Poi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemiaJames S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Circulation|August 30, 2014
Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart AssociationDavid M Maahs, Stephen R Daniels, Sarah D de Ferranti, et al.
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Blood|December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibodyFarrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Scientific Reports|September 15, 2021
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville KentuckyKrystal T Hamorsky, Adrienne M Bushau-Sprinkle, Kathleen Kitterman, et al.
Pageof 7